Gsk (GSK) Net Income towards Common Stockholders (2009 - 2026)
Gsk (GSK) reported Net Income towards Common Stockholders of $2.92 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 8, 2026, Gsk's Net Income towards Common Stockholders came in at $3.16 billion; for the year ended Dec 31, 2025, it was $7.54 billion, up 129.0% from the prior year.
- Net Income towards Common Stockholders has a five-year compound annual growth rate of 0.4% (years ended Dec 2020 to Dec 2025).
- By year, Net Income towards Common Stockholders came in at $3.29 billion in the year ended Dec 31, 2024 (-46.3%), $6.13 billion in the year ended Dec 31, 2023 (-66.9%), $18.51 billion in the year ended Dec 31, 2022 (+206.8%) and $6.03 billion in the year ended Dec 31, 2021 (-18.3%).
- The figure for the quarter ended Sep 8, 2026 ranks as the highest quarterly Net Income towards Common Stockholders since the quarter ended Sep 30, 2022.
- Year over year, Net Income towards Common Stockholders gained in four of the last five quarters, with growth averaging 10.3%.
- The high point for year-over-year Net Income towards Common Stockholders in five years was the quarter ended Sep 30, 2022 (growth of 692.0%); the low point was the quarter ended Sep 30, 2023 (a decline of 85.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 583.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 583.63 Mn |
| Mar 31, 2026 | 2.34 Bn |
| Dec 31, 2025 | -2.68 Bn |
| Sep 30, 2025 | 2.72 Bn |
| Jun 30, 2025 | 1.93 Bn |
| Mar 31, 2025 | 2.05 Bn |
| Dec 31, 2024 | 531.37 Mn |
| Sep 30, 2024 | -75.36 Mn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 1.33 Bn |
| Dec 31, 2023 | 434.40 Mn |
| Sep 30, 2023 | 1.85 Bn |
| Jun 30, 2023 | 2.03 Bn |
| Mar 31, 2023 | 1.81 Bn |
| Dec 31, 2022 | 1.75 Bn |
| Sep 30, 2022 | 12.75 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 2.42 Bn |
| Dec 31, 2021 | 1.01 Bn |
| Sep 30, 2021 | 1.61 Bn |
API Access
Gsk Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();